Blankings target Vicore Pharma ahead of key study results

Short sellers are increasing positions in Vicore Pharma, a major biotech, as the company approaches release of important clinical trial data. The move suggests market skepticism about the study outcomes, which could trigger significant volatility in the stock.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works